Novel and Emerging LDL-C Lowering Strategies: A New Era of Dyslipidemia Management
F Agnello, S Ingala, G Laterra, L Scalia… - Journal of Clinical …, 2024 - mdpi.com
Atherosclerotic cardiovascular disease (ASCVD) represents a major global health
challenge, significantly contributing to mortality rates. This chronic inflammatory condition …
challenge, significantly contributing to mortality rates. This chronic inflammatory condition …
Periprocedural myocardial infarction and injury
M Spagnolo, G Occhipinti, C Laudani… - … Heart Journal: Acute …, 2024 - academic.oup.com
Periprocedural myocardial infarction (PMI) and injury, pertinent to both cardiac and non-
cardiac procedures, have gained increasing recognition in clinical practice. Over time …
cardiac procedures, have gained increasing recognition in clinical practice. Over time …
Gender differences in efficacy and safety of antiplatelet strategies for acute coronary syndromes
G Occhipinti, A Greco, DJ Angiolillo… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Dual antiplatelet therapy (DAPT) represents the cornerstone of secondary
prevention in patients presenting with acute coronary syndrome (ACS) and undergoing …
prevention in patients presenting with acute coronary syndrome (ACS) and undergoing …
Ticagrelor in Clopidogrel-Treated Patients With Chronic Coronary Syndrome Undergoing PCI: Translating Pharmacodynamic Into Clinical Evidence
C Laudani, DJ Angiolillo - Cardiovascular Interventions, 2024 - jacc.org
The number of percutaneous coronary interventions (PCIs) performed has increased over
time, with over 600,000 procedures performed yearly in the United States. Notwithstanding …
time, with over 600,000 procedures performed yearly in the United States. Notwithstanding …
Reply to: Intensified Antithrombotic Regimens After the Initial Period of Double Antiplatelet Therapy: Are We Following the Evidence?
A Greco, D Capodanno - The American Journal of Cardiology, 2023 - search.proquest.com
We thank Lozano et al for their interest in our study on the eligibility to intensified
antithrombotic regimens (ie, prolonged dual antiplatelet therapy [DAPT] and dual pathway …
antithrombotic regimens (ie, prolonged dual antiplatelet therapy [DAPT] and dual pathway …
Intensified Antithrombotic Regimens After the Initial Period of Double Antiplatelet Therapy: Are We Following the Evidence?
I Lozano, J Rondan, JM Vegas - American Journal of Cardiology, 2023 - ajconline.org
We have read with interest the manuscript written by Greco et al 1 about the eligibility for
intensified antithrombotic regimens after the initial period of dual antiplatelet therapy (DAPT) …
intensified antithrombotic regimens after the initial period of dual antiplatelet therapy (DAPT) …